Monday, June 15, 2026

This New DNA Detection Breakthrough Could Change How Scientists Study Cancer Risk

KRISS and Wright State University developed a precise platform to detect ultra-trace damaged DNA, enhancing cancer research and treatment evaluation.

What Does Kim Jong Un’s 78th Army Founding Day Speech Mean for North Korea’s Military Future?

Kim Jong Un visited the Ministry of National Defense to celebrate Military Foundation Day, extending congratulations to military personnel.

Kidney Cancer: Silent but Deadly – Early Detection is Key to Survival

World Cancer Day highlights kidney cancer's rising prevalence in South Korea, emphasizing early detection and lifestyle factors for better outcomes.

Tag: stem cell therapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Stem Cell Therapies Face Long Road to Market Despite Decades of Promise

Stem cell therapies show promise for treating diseases, but face significant commercialization challenges, including quality control and funding.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.